Trial Summary:

A randomised phase III study to determine in women with early breast cancer whether sentinel-node-based management increases the risk of locoregional recurrence and in particular, axillary recurrence, compared with axillary clearance in any subgroup of women.

Supported By:

NHMRC; NZ Cancer Society; multistate Cancer Council funding

Eligibility:

Patients with operable breast cancer, stratified by various factors, including age and tumour size.

Registration ID:

ACTRN12605000409673

Participation:

Australia and New Zealand

Australian Lead Group:

NHMRC CTC

Status:

In follow-up

Activation Date:

5/05/2006

Chairs:

Ian Campbell (ANZ), Neil Wetzig (co-chair ANZ)

Contact:

snac2.study@sydney.edu.au